Investor Relations
FEATURED NEWS
Milestone Scientific Achieves Revenue of $2.7 Million and Provides Business Update for the First Quarter of 2022
ROSELAND, N.J., May 17, 2022 — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update […]
Read More